Continue reading here: BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
Continue reading here: BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
See the rest here: Correction Notice of Palisade Bio’s Press Release Announcing the Appointment of Clinical Advisory Board Members
Visit link: The Novozymes Report 2023
Read more from the original source: Celyad Oncology announces intention to terminate SEC reporting obligations
Here is the original post: Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
Originally posted here: Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
See the original post: Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphoma
Go here to see the original: Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
See original here: Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
Go here to see the original: Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Recent Comments